SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir ($PLTR) is trending as the community anticipates upcoming earnings, with some analysts predicting the stock could double its market cap. Bullish sentiment abounds, with some traders drawing comparisons to other high-growth tech stocks. However, concerns about high valuation and potential for a post-earnings pullback remain discussion points.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is surging on news of a massive, multi-year AI cloud services agreement with Microsoft, driving significant community excitement. Investors are drawing parallels to similar deals in the sector, anticipating a substantial upside, while also highlighting the company's strategic positioning in the AI infrastructure space. The conversation also involves speculation around potential earnings catalysts and further expansion opportunities.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

LCID is trending amid concerns about its financial health and the overall EV market, despite partnerships with Nvidia and Uber. The community is discussing potential dilution, comparing it unfavorably to Tesla, and questioning its long-term viability. Bearish sentiment seems to be dominating, with some anticipating further declines and new all-time lows.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as traders discuss whether it's setting up for a similar breakout to Amazon, focusing on accumulation patterns and potential FOMO. Some investors are frustrated with the stock's recent performance despite positive earnings, while others see it as an undervalued long-term play, especially with upcoming events like the World Cup and Olympics.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

LLY is trending as investors digest recent news, including strong phase 3 data for its oral GLP-1 orforglipron and potential impacts from government negotiations on drug pricing. Community discussions revolve around the drug's potential, target prices, and the ongoing competition within the weight loss and diabetes markets. Some are also discussing potential deals in the sector.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is trending following positive clinical data from its TERN-701 trial, selected for oral presentation at an upcoming hematology conference, driving speculation of a potential buyout. Community members are weighing the bullish data against a recent $300M shelf registration, debating short-squeeze potential versus dilution risks. The focus shifts to TERN's oncology program after the discontinuation of their GLP-1 candidate, with some viewing it as a streamlined path to acquisition.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a mix of factors, including reactions to a recent lawsuit against a former colleague and anticipation of upcoming earnings. The community is actively discussing the potential impact of these events, with some speculating about leaked results and others focused on technical analysis and potential price movements. Overall, the sentiment is mixed, with both bullish and bearish viewpoints expressed.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending due to a volatile reaction to recent FDA feedback regarding its Huntington's disease treatment, AMT-130; while the company believes the FDA is aligned for accelerated approval, the agency has voiced concerns around data adequacy. The community is actively debating the FDA's shifting stance, potential delays, and the overall implications for the company's future, with some suggesting a possible buyout while some expect that $QURE is overvalued.

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

Enveric Biosciences ($ENVB) is trending due to community discussion around its low float, with many eyeing the stock for potential short squeeze opportunities similar to other recent runners. Speculation includes potential news catalysts and a possible shift in focus towards digital asset treasury strategies. Some investors are also highlighting the company's intellectual property and potential settlement opportunities with AbbVie.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana (SOL) is trending as the community discusses its potential to recapture higher price levels, with some eyeing key demand zones for potential bounces. Technical analysis is being shared, with traders watching for breakouts or breakdowns from current levels. Bullish sentiment remains for the long term, with some highlighting Solana's fundamentals and real-world asset tokenization potential.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hubbell (HUBB) Tops Q3 Earnings Estimates

Hubbell (HUBB) delivered earnings and revenue surprises of +3.61% and -1.82%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

New tech solves every pet owner's worst nightmare

My daughter's cat, Bisous (that's French for "kisses") lurks by the front door morning, noon, and night.She is desperate to be outside, but it's not safe for her because we live in a place where...

Apogee Surpasses Earnings Estimates in Q2, Lowers FY26 Outlook

APOG beats Q2 earnings and revenue estimates on UW Solutions gains but trims its FY26 outlook amid margin pressure.

New Strong Buy Stocks for October 10th

EGAN, MDB, INVA, LIF and PGR have been added to the Zacks Rank #1 (Strong Buy) List on October 10th, 2025.

Life360 (LIF) is on the Move, Here's Why the Trend Could be Sustainable 

Life360 (LIF) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

ClearSign Technologies Secures Initial Engineering Order for 32-Burner

CLIR lands its first engineering order for a 32-burner retrofit at a major California refinery.


All You Need to Know About Life360 (LIF) Rating Upgrade to Strong Buy

Life360 (LIF) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is AZZ (AZZ) Stock Outpacing Its Industrial Products Peers This Year?

Here is how AZZ (AZZ) and Life360 (LIF) have performed compared to their sector so far this year.

Greif Optimizes Portfolio With Timberlands Business Sale

GEF sells its timberlands business for $462M, aiming to cut debt, boost efficiency and focus on higher-margin markets.

DOV Gains From Healthy Bookings Despite Low Vehicle Service Volumes

Dover gains from strong bookings, acquisitions and portfolio moves, even as vehicle service volumes affect margins.

Life360, Inc. engages in the development of location sharing mobile applications. It offers mobile applications, which include features that range from communications to driving safety and location sharing. It operates through the following geographical segments: North America, Europe, Middle East, and Africa, and Other International Regions. The company was founded by Chris Hulls, Dilpreet Singh, and Alex Haro in 2007 and is headquartered in San Mateo, CA.

Life360 Inc.

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.17	--	--	N/A
Q2 '25	$0.13	$0.26	101.16%	BEAT
Q1 '25	$0.00	$0.17	6353.81%	BEAT
Q4 '24	$0.15	$0.24	65.04%	BEAT
Q3 '24	$0.10	$0.27	181.37%	BEAT

LIF
Life360 Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest LIF News

LIFLife360 Inc.